Merck & Co., Inc.
MRK
$125.78
$0.550.44%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 60.11B | 59.31B | 58.31B | 57.87B | 59.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.11B | 59.31B | 58.31B | 57.87B | 59.28B |
| Cost of Revenue | 15.92B | 15.96B | 15.61B | 15.77B | 17.21B |
| Gross Profit | 44.20B | 43.35B | 42.70B | 42.10B | 42.08B |
| SG&A Expenses | 9.48B | 9.82B | 9.75B | 9.67B | 9.49B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.14B | 49.75B | 49.53B | 39.06B | 38.61B |
| Operating Income | 4.97B | 9.57B | 8.78B | 18.81B | 20.67B |
| Income Before Tax | 1.89B | 7.45B | 5.41B | 15.23B | 16.44B |
| Income Tax Expenses | 1.51B | 2.83B | 2.29B | 2.19B | 1.92B |
| Earnings from Continuing Operations | 377.00 | 4.62K | 3.12K | 13.05K | 14.53K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.00M | -13.00M | -13.00M | -15.00M | -8.00M |
| Net Income | 365.00M | 4.61B | 3.11B | 13.03B | 14.52B |
| EBIT | 4.97B | 9.57B | 8.78B | 18.81B | 20.67B |
| EBITDA | 8.70B | 13.27B | 12.44B | 22.47B | 24.46B |
| EPS Basic | 0.14 | 1.82 | 1.23 | 5.14 | 5.74 |
| Normalized Basic EPS | 0.92 | 2.26 | 2.05 | 4.51 | 4.97 |
| EPS Diluted | 0.13 | 1.80 | 1.22 | 5.12 | 5.71 |
| Normalized Diluted EPS | 0.91 | 2.24 | 2.04 | 4.49 | 4.95 |
| Average Basic Shares Outstanding | 10.15B | 10.15B | 10.15B | 10.14B | 10.13B |
| Average Diluted Shares Outstanding | 10.17B | 10.18B | 10.18B | 10.18B | 10.17B |
| Dividend Per Share | 2.92 | 2.88 | 2.84 | 2.80 | 2.76 |
| Payout Ratio | 2,039.73% | 159.35% | 232.56% | 54.64% | 48.30% |
